Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

Hofseth Biocare ASA : Second Quarter Results 2013

27.08.2013

Hofseth Biocare ASA : Mandatory Notification of Trade in Hofseth BioCare ASA

26.08.2013

Hofseth Biocare ASA : Mandatory Notification of Trade and disclosure of large shareholdings in Hofseth BioCare ASA

26.08.2013

Hofseth Biocare ASA : Mandatory notification of trade in Hofseth BioCare ASA

26.08.2013

Hofseth Biocare ASA :Invitation to presentation of second quarter 2013 results

23.08.2013

Hofseth Biocare ASA : Study shows OxLDL-GP as a important CVD marker that tracks family history of CVD

29.07.2013

Hofseth Biocare ASA : Mandatory notification of Trade

25.07.2013

Hofseth Biocare ASA : Salmon oil patent granted in Australia

18.07.2013

Hofseth Biocare ASA : Share capital increase registered

05.07.2013

Hofseth Biocare ASA : Completed Private Placement in Hofseth BioCare ASA

27.06.2013

Previous
20 21 22
23
24 25 26
...
31
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies